Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,107 | 110,949 | 126,884 | 117,709 | 101,084 |
| Marketable Securities | N/A | N/A | 1,205 | 59,711 | 108,684 |
| Receivables | 42,744 | 37,211 | 72,482 | 102,589 | 78,045 |
| Inventories | 3,412 | 3,396 | 13,042 | 13,033 | 10,494 |
| TOTAL | $103,951 | $208,107 | $230,851 | $306,204 | $308,972 |
| Non-Current Assets | |||||
| PPE Net | 3,497 | 13,064 | 13,024 | 15,526 | 14,794 |
| Investments And Advances | 13,064 | 11,784 | 0 | 0 | 0 |
| Intangibles | 400,535 | 692,099 | 793,873 | 902,149 | 1,008,994 |
| Other Non-Current Assets | 6,123 | 7,812 | 869 | 1,458 | 24,489 |
| TOTAL | $423,219 | $724,759 | $807,766 | $919,133 | $1,048,277 |
| Total Assets | $527,170 | $932,866 | $1,038,617 | $1,225,337 | $1,357,249 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 80,000 | 120,000 | 82,500 | N/A | N/A |
| Accounts payable and accrued liabilities | 24,568 | 17,783 | 27,952 | 30,779 | 31,477 |
| Accrued Expenses | 77,891 | 107,120 | 196,324 | 190,934 | 183,989 |
| Other current liabilities | 2,094 | 1,133 | 3,678 | 5,470 | 4,166 |
| TOTAL | $184,553 | $246,036 | $310,580 | $227,242 | $219,632 |
| Non-Current Liabilities | |||||
| Long Term Debt | 271,258 | 158,309 | 274,720 | 466,051 | 563,012 |
| Other Non-Current Liabilities | 13,401 | 308,186 | 283,809 | 281,256 | 259,550 |
| TOTAL | $284,659 | $466,495 | $558,529 | $747,307 | $822,562 |
| Total Liabilities | $469,212 | $712,531 | $869,109 | $974,549 | $1,042,194 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,322 | 16,066 | 15,876 | 15,525 | 15,226 |
| Common Shares | 8 | 6 | 6 | 291,634 | 264,511 |
| Retained earnings | -399,801 | -182,600 | -219,508 | -116,744 | -28,024 |
| Other shareholders' equity | 0 | -5 | -5 | -19 | -54 |
| TOTAL | $57,958 | $220,335 | $169,508 | $250,788 | $315,055 |
| Total Liabilities And Equity | $527,170 | $932,866 | $1,038,617 | $1,225,337 | $1,357,249 |